Amarin Corp PLC (NAS:AMRN)
$ 0.704 -0.0208 (-2.93%) Market Cap: 289.25 Mil Enterprise Value: -10.54 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 43/100

Amarin Corporation PLC at Cowen Health Care Conference Transcript

Mar 13, 2019 / 12:00PM GMT
Release Date Price: $20.46 (-3.99%)
Irina Margine
Cowen and Company, LLC, Research Division - Research Associate

Good morning, everyone, and welcome to Cowen's 2019 Health Care Conference. My name is Irina Margine. I'm on the Biotech Equity Research Team.

And it is my pleasure to introduce this morning, John Thero, CEO of Amarin.

John F. Thero
Amarin Corporation plc - President, CEO & Director

Thank you for that introduction. And thanks, everybody, for joining me here this morning. We've made a lot of progress since Cowen's last Health Care Conference, and I think we'll make a lot of progress between now and next Cowen's Health Care Conference. And since I've already jumped into forward-looking statements, I will disclaim that there are risks involved with all such statements, anybody considering investing should review our risk factors as filed in our SEC statements.

So Amarin is in the cardiovascular space and, cardiovascular disease, as hopefully you know, is an enormous and worsening public health burden. We see an urgent need and that, the current solutions out

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot